Sex Hormones and the Immune System: Implications for Menopause and Autoimmunity
Reference51 articles.
1. Jilka R, Hangok G, Girasole G, et al. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992; 257:88–91.
2. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994; 94:2397–406.
3. Kimble RB, Kitazawa R, Vannice JL, Pacifici R. Persistent bone-sparing effect of interleukin-1 receptor antagonist: A hypothesis on the role of IL-1 in ovarieetomy-induced bone loss. Calcif Tissue Int 1994; 55:260–65.
4. Mor G, Naftolin F. Oestrogen, menopause and the immune system. JBMS 1998; 4:4–8.
5. van der Meer JW, Vogels MT, Netea MG, Kullberg BJ. Proinflammatory cytokines and treatment of disease. Ann N Y Acad Sci 1998; 856:243–51.